SYMPTOMATIC DERMOGRAPHISM
Clinical trials for SYMPTOMATIC DERMOGRAPHISM explained in plain language.
Never miss a new study
Get alerted when new SYMPTOMATIC DERMOGRAPHISM trials appear
Sign up with your email to follow new studies for SYMPTOMATIC DERMOGRAPHISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First test of new hives drug begins in humans
Disease control Recruiting nowThis is the first study in people to test the safety of a new drug called GTX-B001. It will be given as a single dose to 48 healthy volunteers and 24 people with chronic hives triggered by cold or scratching. The main goal is to see how safe the drug is and how the body processes…
Matched conditions: SYMPTOMATIC DERMOGRAPHISM
Phase: PHASE1 • Sponsor: Granular Therapeutics Limited • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug trial targets uncontrollable skin reactions to cold and touch
Disease control Recruiting nowThis study is testing an investigational drug called barzolvolimab for adults whose skin breaks out in itchy hives from cold temperatures or light scratching, even while taking standard allergy medications. About 240 participants will receive either the drug or a placebo injectio…
Matched conditions: SYMPTOMATIC DERMOGRAPHISM
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC